(S (NP (NN Hypertension)) (VP (VBZ is) (NP (NP (DT a) (JJ medical) (NN condition)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (ADJP (RB well) (HYPH -) (VBN established)) (PP (IN as) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (JJ many) (JJ major) (NNS diseases))))))))))) (. .))
(S (PP (IN For) (NP (NN example))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB cause) (NP (NNS alterations)) (PP (IN in) (NP (NP (DT the) (JJ cardiac) (NN structure) (CC and) (NN function)) (PP (IN over) (NP (NP (NN time)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB lead) (PP (IN to) (NP (ADJP (NN heart) (VBN related)) (NML (NN morbidity) (CC and) (NN mortality)))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN at) (NP (DT the) (JJ subclinical) (NN stage))) (, ,) (NP (DT these) (NNS changes)) (VP (VP (VBP are) (ADJP (JJ subtle))) (CC and) (VP (MD can) (RB not) (VP (VB be) (ADVP (RB easily)) (VP (VBN captured) (S (VP (VBG using) (NP (NP (JJ conventional) (JJ cardiovascular) (NNS indices)) (VP (VBN calculated) (PP (IN from) (NP (JJ clinical) (JJ cardiac) (NN imaging))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP describe) (SBAR (S (NP (DT a) (NNS radiomics)) (VP (VBP approach) (PP (IN for) (S (VP (VBG identifying) (NP (NP (NML (JJ intermediate) (NN imaging)) (NNS phenotypes)) (VP (VBN associated) (PP (IN with) (NP (NN hypertension)))))))))))) (. .))
(S (NP (DT The) (NN method)) (VP (VBZ combines) (NP (NN feature) (NML (NN selection) (CC and) (NN machine)) (NN learning) (NNS techniques)) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (ADJP (RBS most) (JJ subtle))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ complex) (UCP (JJ structural) (CC and) (NN tissue)) (NNS changes)) (PP (IN in) (NP (JJ hypertensive) (NNS subgroups))))) (PP (IN as) (VBN compared) (PP (IN to) (NP (JJ healthy) (NNS individuals)))))))) (. .))
(S (NP (NP (NN Validation)) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (NP (JJ asymptomatic) (NNS hearts)) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (DT both) (ADJP (JJ hypertensive) (CC and) (JJ non-hypertensive)) (NNS cases))))))))))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (VBN proposed) (NNS radiomics) (NN model)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG detecting) (NP (NP (NN intensity)) (CC and) (NP (JJ textural) (NNS changes))) (PP (RB well) (IN beyond) (NP (NP (DT the) (NNS capabilities)) (PP (IN of) (NP (NML (JJ conventional) (NN imaging)) (NNS phenotypes))))) (, ,) (S (VP (VBG indicating) (NP (PRP$ its) (NN potential)) (PP (IN for) (NP (NP (VBN improved) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ longitudinal) (NNS effects)) (PP (IN of) (NP (NP (NN hypertension)) (PP (IN on) (NP (JJ cardiovascular) (NN health) (CC and) (NN disease))))))))))))))))))) (. .))
